Ranked All-Publication list | Historiographs | Glossary HistCite Guide About |
Nodes: 6555, Authors: 15733, Journals: 1105, Cited References: 140610, Words: 8620, Tags: 1
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country |
View: Overview | Sorted by journal name. |
Page 10 of 66: [ 1 2 3 4 5 6 7 8 9 10 ] 11 21 31 41 51 61
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
---|---|---|---|---|---|
901 | 5 | 225 | 5760 2005 BRAIN RESEARCH REVIEWS 50 (1): 69-85 White MK; Gordon J; Reiss K; Del Valle L; Croul S; et al. Human polyomaviruses and brain tumors | 0 | 1 |
902 | 15 | 36 | 1848 1996 BRAZILIAN JOURNAL OF GENETICS 19 (2): 313-318 Guerra M; Kenton A Distribution of telomere DNA in mitotic and polytene nuclei of the anther tapetum of a tetraploid hybrid bean, Phaseolus vulgaris x P-acutifolius | 1 | 5 |
903 | 3 | 53 | 5761 2005 BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH 38 (7): 995-1014 Scandalios JG Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses | 0 | 5 |
904 | 14 | 15 | 2941 1999 BREAST 8 (4): 208-211 Mokbell K; Parris CN; Ghilchik M; Newbold RF Telomerase activity in the human breast | 1 | 6 |
905 | 15 | 25 | 3781 2001 BREAST CANCER RESEARCH 3 (3): 146-149 Herbert BS; Wright WE; Shay JW Telomerase and breast cancer | 7 | 16 |
906 | 2 | 27 | 3782 2001 BREAST CANCER RESEARCH 3 (4): 209-212 Hulit J; Di Vizio D; Pestell RG Inducible transgenics. New lessons on events governing the induction and commitment in mammary tumorigenesis | 0 | 6 |
907 | 13 | 26 | 4222 2002 BREAST CANCER RESEARCH 5 (1): 37-41 Artandi SE Complex roles for telomeres and telomerase in breast carcinogenesis | 0 | 3 |
908 | 13 | 86 | 1269 1993 BREAST CANCER RESEARCH AND TREATMENT 25 (1): 83-94 SHAY JW; WRIGHT WE; WERBIN H TOWARD A MOLECULAR UNDERSTANDING OF HUMAN BREAST-CANCER - A HYPOTHESIS | 28 | 47 |
909 | 16 | 32 | 2942 1999 BREAST CANCER RESEARCH AND TREATMENT 58 (1): 65-69 Shpitz B; Zimlichman S; Zemer R; Bomstein Y; Zehavi T; et al. Telomerase activity in ductal carcinoma in situ of the breast | 7 | 14 |
910 | 12 | 22 | 3783 2001 BREAST CANCER RESEARCH AND TREATMENT 65 (2): 93-99 Tejera AM; Alonso DF; Gomez DE; Olivero OA Chronic in vitro exposure to 3 '-azido-2 ', 3 '-dideoxythymidine induces senescence and apoptosis and reduces tumorigenicity of metastatic mouse mammary tumor cells | 8 | 15 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
911 | 22 | 37 | 4718 2003 BREAST CANCER RESEARCH AND TREATMENT 77 (3): 277-284 Kirkpatrick KL; Ogunkolade W; Elkak AE; Bustin S; Jenkins P; et al. hTERT expression in human breast cancer and non-cancerous breast tissue: correlation with tumour stage and c-Myc expression | 3 | 5 |
912 | 0 | 0 | 5223 2004 BREAST CANCER RESEARCH AND TREATMENT 88: S2-S2 Li S; Xu L; Warner CL; Rosenberg J; Botchkina IL; et al. Interventions in telomerase acton in human cancer cells | 0 | 0 |
913 | 20 | 35 | 5762 2005 BREAST CANCER RESEARCH AND TREATMENT 93 (3): 227-236 Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; et al. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss | 0 | 0 |
914 | 15 | 24 | 6284 2006 BREAST CANCER RESEARCH AND TREATMENT 96 (1): 73-81 Gellert GC; Dikmen ZG; Wright WE; Gryaznov S; Shay JW Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer | 1 | 2 |
915 | 11 | 18 | 2505 1998 BRITISH JOURNAL OF BIOMEDICAL SCIENCE 55 (3): 221-225 Mera SL The role of telomeres in ageing and cancer | 0 | 4 |
916 | 28 | 47 | 1849 1996 BRITISH JOURNAL OF CANCER 73 (1): 1-4 Parkinson EK Do telomerase antagonists represent a novel anti-cancer strategy? | 42 | 56 |
917 | 17 | 30 | 2155 1997 BRITISH JOURNAL OF CANCER 75 (4): 548-553 Yoshida K; Sugino T; Goodison S; Warren BF; Nolan D; et al. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications | 37 | 73 |
918 | 16 | 21 | 2506 1998 BRITISH JOURNAL OF CANCER 77 (10): 1633-1637 Sano T; Asai A; Mishima K; Fujimaki T; Kirino T Telomerase activity in 144 brain tumours | 17 | 29 |
919 | 10 | 26 | 2507 1998 BRITISH JOURNAL OF CANCER 77 (12): 2177-2180 Cheng AJ; Lin JD; Chang T; Wang TCV Telomerase activity in benign and malignant human thyroid tissues | 16 | 31 |
920 | 16 | 28 | 2508 1998 BRITISH JOURNAL OF CANCER 78 (7): 933-939 Mutirangura A; Sriuranpong V; Termrunggraunglert W; Tresukosol D; Lertsaguansinchai P; et al. Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions | 13 | 33 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
921 | 22 | 32 | 2943 1999 BRITISH JOURNAL OF CANCER 79 (1): 47-53 Parris CN; Jezzard S; Silver A; MacKie R; McGregor JM; et al. Telomerase activity in melanoma and non-melanoma skin cancer | 11 | 30 |
922 | 3 | 69 | 2944 1999 BRITISH JOURNAL OF CANCER 79 (3-4): 377-385 Okada F; Nakai K; Kobayashi T; Shibata T; Tagami S; et al. Inflammatory cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells | 0 | 17 |
923 | 29 | 41 | 2945 1999 BRITISH JOURNAL OF CANCER 80 (9): 1332-1341 Raymond E; Sun D; Izbicka E; Mangold G; Silvas E; et al. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay | 7 | 14 |
924 | 26 | 32 | 3352 2000 BRITISH JOURNAL OF CANCER 82 (3): 601-607 Remes K; Norrback KF; Rosenquist R; Mehle C; Lindh J; et al. Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse | 15 | 19 |
925 | 19 | 44 | 3353 2000 BRITISH JOURNAL OF CANCER 82 (12): 1946-1951 Chang JTC; Liao CT; Jung SM; Wang TCV; See LC; et al. Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues | 4 | 9 |
926 | 21 | 59 | 3354 2000 BRITISH JOURNAL OF CANCER 83 (7): 841-846 Hayflick L The illusion of cell immortality | 7 | 31 |
927 | 12 | 25 | 3784 2001 BRITISH JOURNAL OF CANCER 84 (11): 1551-1555 Akeshima R; Kigawa J; Takahashi M; Oishi T; Kanamori Y; et al. Telomerase activity and p53-dependent apoptosis in ovarian cancer cells | 1 | 4 |
928 | 22 | 30 | 3785 2001 BRITISH JOURNAL OF CANCER 85 (5): 752-757 Yajima T; Yagihashi A; Kameshima H; Kobayashi D; Hirata K; et al. Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells | 3 | 7 |
929 | 22 | 50 | 3786 2001 BRITISH JOURNAL OF CANCER 85 (10): 1510-1514 Miura N; Onuki N; Rathi A; Virmani A; Nakamoto S; et al. hTR repressor-related gene on human chromosome 10p15.1 | 1 | 6 |
930 | 24 | 39 | 4719 2003 BRITISH JOURNAL OF CANCER 88 (4): 593-598 Hultdin M; Rosenquist R; Thunberg U; Tobin G; Norrback KF; et al. Association between telomere length and V-H gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications | 3 | 10 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
931 | 31 | 44 | 4720 2003 BRITISH JOURNAL OF CANCER 89 (4): 713-719 Klapper W; Krams M; Qian W; Janssen D; Parwaresch R Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation | 6 | 9 |
932 | 18 | 47 | 4721 2003 BRITISH JOURNAL OF CANCER 89 (5): 922-929 Kanzawa T; Germano IM; Kondo Y; Ito H; Kyo S; et al. Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide | 1 | 3 |
933 | 8 | 38 | 4722 2003 BRITISH JOURNAL OF CANCER 89 (6): 1091-1095 Gabellini C; Antonelli A; Petrinelli P; Biroccio A; Marcucci L; et al. Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1 | 0 | 0 |
934 | 24 | 46 | 5224 2004 BRITISH JOURNAL OF CANCER 91 (5): 972-979 Hiyama E; Yamaoka H; Matsunaga T; Hayashi Y; Ando H; et al. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma | 2 | 3 |
935 | 24 | 57 | 5763 2005 BRITISH JOURNAL OF CANCER 92 (10): 1881-1891 Uziel O; Fenig E; Nordenberg J; Beery E; Reshef H; et al. Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines | 1 | 4 |
936 | 19 | 28 | 5764 2005 BRITISH JOURNAL OF CANCER 92 (10): 1942-1947 Ohyashiki JH; Hisatomi H; Nagao K; Honda S; Takaku T; et al. Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cells | 2 | 4 |
937 | 4 | 45 | 5765 2005 BRITISH JOURNAL OF CANCER 93 (1): 116-123 Maeda T; Tashiro H; Katabuchi H; Begum M; Ohtake H; et al. Establishment of an immortalised human ovarian surface epithelial cell line without chromosomal instability | 0 | 1 |
938 | 16 | 31 | 6285 2006 BRITISH JOURNAL OF CANCER 94 (3): 341-345 Seimiya H The telomeric PARP, tankyrases, as targets for cancer therapy | 0 | 0 |
939 | 4 | 9 | 3355 2000 BRITISH JOURNAL OF DERMATOLOGY 142 (5): 1060-1061 Tosi P; Miracco C; Santopietro R; Pacenti L; Perotti R; et al. Possible diagnostic role of telomerase activity evaluation in the differential diagnosis between Spitz naevi and cutaneous malignant melanoma | 1 | 5 |
940 | 16 | 43 | 4223 2002 BRITISH JOURNAL OF DERMATOLOGY 147 (2): 250-254 Ohtsuka T; Yamakage A; Yamazaki S The polymorphism of telomerase RNA component gene in patients with systemic sclerosis | 1 | 1 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
941 | 9 | 50 | 5225 2004 BRITISH JOURNAL OF DERMATOLOGY 150 (1): 56-63 Gilhar A; Ullmann Y; Karry R; Shalaginov R; Assy B; et al. Ageing of human epidermis: the role of apoptosis, Fas and telomerase | 1 | 6 |
942 | 5 | 10 | 5226 2004 BRITISH JOURNAL OF DERMATOLOGY 150 (2): 388-390 Hu S; Liao SK; Pang JHS; Chen MC; Chen CH; et al. Screening of inhibitors of human telomerase reverse transcriptase in a cultured malignant melanoma cell line | 0 | 0 |
943 | 27 | 43 | 2509 1998 BRITISH JOURNAL OF HAEMATOLOGY 100 (1): 156-165 Seol JG; Kim ES; Park WH; Jung CW; Kim BK; et al. Telomerase activity in acute myelogenous leukaemia: clinical and biological implications | 2 | 19 |
944 | 31 | 39 | 2510 1998 BRITISH JOURNAL OF HAEMATOLOGY 102 (5): 1367-1375 Xu DW; Gruber A; Peterson C; Pisa P Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia | 18 | 50 |
945 | 10 | 22 | 2511 1998 BRITISH JOURNAL OF HAEMATOLOGY 103 (3): 591-593 Wynn RF; Cross RA; Testa NG Telomeres and haemopoiesis | 2 | 5 |
946 | 21 | 30 | 2946 1999 BRITISH JOURNAL OF HAEMATOLOGY 104 (4): 785-794 Tu WW; Zhang DK; Cheung PT; Tsao SW; Lau YL Effect of insulin-like growth factor 1 on PHA-stimulated cord blood mononuclear cell telomerase activity | 3 | 14 |
947 | 23 | 59 | 2947 1999 BRITISH JOURNAL OF HAEMATOLOGY 105 (4): 883-893 Leteurtre F; Li X; Guardiola P; Le Roux G; Sergere JC; et al. Accelerated telomere shortening and telomerase activation in Fanconi's anaemia | 17 | 38 |
948 | 17 | 31 | 2948 1999 BRITISH JOURNAL OF HAEMATOLOGY 105 (4): 997-1001 Wynn R; Thornley I; Freedman M; Saunders EF Telomere shortening in leucocyte subsets of long-term survivors of allogeneic bone marrow transplantation | 12 | 31 |
949 | 26 | 52 | 3356 2000 BRITISH JOURNAL OF HAEMATOLOGY 109 (2): 272-279 Robertson JD; Gale RE; Wynn RF; Dougal M; Linch DC; et al. Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns | 20 | 29 |
950 | 1 | 24 | 3357 2000 BRITISH JOURNAL OF HAEMATOLOGY 109 (2): 447-452 Saheki K; Fujimori Y; Takemoto Y; Kakishita E Increased expression of Fas (APO-1, CD95) on CD34(+) haematopoietic progenitor cells after allogeneic bone marrow transplantation | 0 | 6 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
951 | 11 | 42 | 3358 2000 BRITISH JOURNAL OF HAEMATOLOGY 110 (2): 327-338 Minamiguchi H; Yahata N; Kimura T; Fujiki H; Harada S; et al. Interleukin 6 receptor expression by human cord blood-or peripheral blood-derived primitive haematopoietic progenitors implies acquisition of different functional properties | 0 | 10 |
952 | 22 | 38 | 3787 2001 BRITISH JOURNAL OF HAEMATOLOGY 112 (4): 1025-1030 Lee JJ; Kook H; Chung IJ; Na JA; Park MR; et al. Telomere length changes in patients with aplastic anaemia | 10 | 12 |
953 | 9 | 132 | 3788 2001 BRITISH JOURNAL OF HAEMATOLOGY 113 (1): 11-23 Holyoake TL Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: Lessons to be learned from the laboratory | 0 | 11 |
954 | 6 | 12 | 4224 2002 BRITISH JOURNAL OF HAEMATOLOGY 117 (1): 189-192 Thornley I; Dror Y; Sung L; Wynn RF; Freedman MH Abnormal telomere shortening in leucocytes of children with Shwachman-Diamond syndrome | 0 | 9 |
955 | 42 | 63 | 4225 2002 BRITISH JOURNAL OF HAEMATOLOGY 119 (3): 810-818 Martens UM; Brass V; Sedlacek L; Pantic M; Exner C; et al. Telomere maintenance in human B lymphocytes | 8 | 16 |
956 | 20 | 47 | 4723 2003 BRITISH JOURNAL OF HAEMATOLOGY 120 (2): 329-336 Szyper-Kravitz M; Uziel O; Shapiro H; Radnay J; Katz T; et al. Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34(+) haematopoietic cells and may prevent telomere attrition after chemotherapy | 6 | 11 |
957 | 16 | 38 | 4724 2003 BRITISH JOURNAL OF HAEMATOLOGY 120 (5): 836-845 Li XX; Leteurtre F; Rocha V; Guardiola P; Berger R; et al. Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia | 2 | 8 |
958 | 27 | 60 | 3359 2000 BRITISH JOURNAL OF OPHTHALMOLOGY 84 (2): 217-223 Heine B; Coupland SE; Kneiff S; Demel G; Bornfeld N; et al. Telomerase expression in uveal melanoma | 1 | 5 |
959 | 10 | 32 | 1850 1996 BRITISH JOURNAL OF RHEUMATOLOGY 35 (8): 732-737 Artlett CM; Black CM; Briggs DC; Stevens CO; Welsh KI Telomere reduction in scleroderma patients: A possible cause for chromosomal instability | 4 | 11 |
960 | 15 | 35 | 2512 1998 BRITISH JOURNAL OF SURGERY 85 (7): 965-969 Scates DK; Clark SK; Phillips RKS; Venitt S Lack of telomerase in desmoids occurring sporadically and in association with familial adenomatous polyposis | 0 | 12 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
961 | 16 | 30 | 2949 1999 BRITISH JOURNAL OF SURGERY 86 (5): 674-679 Koyanagi K; Ozawa S; Ando N; Takeuchi H; Ueda M; et al. Clinical significance of telomerase activity in the non-cancerous epithelial region of oesophageal squamous cell carcinoma | 4 | 13 |
962 | 3 | 185 | 3360 2000 BRITISH JOURNAL OF SURGERY 87 (7): 840-853 Manu M; Buckels J; Bramhall S Molecular technology and pancreatic cancer | 0 | 9 |
963 | 23 | 30 | 1851 1996 BRITISH JOURNAL OF UROLOGY 78 (5): 704-708 Kamata S; Kageyama Y; Yonese J; Oshima H Significant telomere reduction in human superficial transitional cell carcinoma | 8 | 16 |
964 | 8 | 54 | 2513 1998 BRITISH JOURNAL OF UROLOGY 82 (5): 647-654 Halachmi S; Linn JF; Amiel GE; Moskovitz B; Nativ O Urine cytology, tumour markers and bladder cancer | 3 | 18 |
965 | 1 | 11 | 454 1987 BRITISH MEDICAL JOURNAL 295 (6606): 1121-1123 LASKEY RA THE CELL-NUCLEUS | 0 | 1 |
966 | 45 | 57 | 2156 1997 BULLETIN DU CANCER 84 (10): 963-970 Soria JC; Rixe O Telomeres, telomerase and cancer | 2 | 4 |
967 | 32 | 49 | 2157 1997 BULLETIN DU CANCER 84 (12): 1123-1133 Raymond E; Faivre S; Dieras V; Von Hoff D Inhibition of telomeres and telomerase. Seeking for new anticancer drugs | 3 | 4 |
968 | 5 | 44 | 2514 1998 BULLETIN DU CANCER 85 (1): 83-88 Lavelle F; Jehanno A Antitumor agents: Realities and perspectives in 1998 | 0 | 0 |
969 | 32 | 38 | 2515 1998 BULLETIN DU CANCER 85 (2): 119-123 Gilson E 1997, a good year for telomerase? | 0 | 1 |
970 | 36 | 73 | 4725 2003 BULLETIN DU CANCER 90 (4): 305-313 Riou JF; Gomez D; Lemarteleur T; Trentesaux C G-quadruplex DNA: myth or reality? | 4 | 4 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
971 | 41 | 59 | 5766 2005 BULLETIN DU CANCER 92 (1): 13-22 Riou JF; Gomez D; Mergny JL; Guittat L; Paterski R; et al. Regulation of telomeres length: getting access to telomeres | 0 | 0 |
972 | 60 | 99 | 6286 2006 BULLETIN DU CANCER 93: 71-82 Olaussen KA; Sabatier L; Besse B; Soria JC Telomeres and telomerase as therapeutic targets in the treatment of cancer | 0 | 0 |
973 | 8 | 77 | 2516 1998 BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE 126 (7): 643-652 Bebikhov DV; Postnov AY; Nikinenko TA Role of retroposition in autoregulation of genomic processes (Do genes program the body and retroposons program the genome?) | 0 | 0 |
974 | 7 | 15 | 5227 2004 BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE 138 (5): 501-503 Todriya TV; Tzander A Telomerase activity in cells of 9-day-old spleen colonies formed by bone marrow of normal and thymectomized mice | 0 | 0 |
975 | 3 | 81 | 4226 2002 CALCIFIED TISSUE INTERNATIONAL 71 (5): 447-458 Osyczka AM; Noth U; O'Connor J; Caterson EJ; Yoon K; et al. Multilineage differentiation of adult human bone marrow progenitor cells transduced with human papilloma virus type 16 E6/E7 genes | 0 | 11 |
976 | 3 | 26 | 73 1978 CANADIAN JOURNAL OF BIOCHEMISTRY 56 (1): 23-28 CHEEMADHADLI S; HALPERIN ML AMMONIAGENESIS IN KIDNEY CORTEX MITOCHONDRIA OF RAT - ROLE OF MITOCHONDRIAL DICARBOXYLATE ANION TRANSPORTER | 0 | 14 |
977 | 3 | 30 | 112 1981 CANADIAN JOURNAL OF BIOCHEMISTRY 59 (6): 396-403 GANZ PR; KISS GB; PEARLMAN RE OLIGO(A)-STIMULATED TETRAHYMENA RDNA SYNTHESIS INVITRO | 2 | 2 |
978 | 9 | 28 | 133 1982 CANADIAN JOURNAL OF BIOCHEMISTRY 60 (9): 847-853 BRUNK CF; TSAO SGS; DIAMOND CH; OHASHI PS; TSAO NNG; et al. REORGANIZATION OF UNIQUE AND REPETITIVE SEQUENCES DURING NUCLEAR DEVELOPMENT IN TETRAHYMENA-THERMOPHILA | 26 | 37 |
979 | 2 | 26 | 3361 2000 CANADIAN JOURNAL OF GASTROENTEROLOGY 14 (2): 99-110 Wild GE; Papalia P; Ropeleski MJ; Faria J; Thomson ABR Applications of recombinant DNA technology in gastrointestinal medicine and hepatology: Basis paradigms of molecular cell biology. Part A: Eukaryotic gene structure and DNA replication | 0 | 1 |
980 | 2 | 45 | 3362 2000 CANADIAN JOURNAL OF MICROBIOLOGY 46 (7): 593-599 Varga J; Kevei E; Toth B; Kozakiewicz Z; Hoekstra R Molecular analysis of variability within the toxigenic Aspergillus ochraceus species | 0 | 14 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
981 | 34 | 50 | 1612 1995 CANADIAN JOURNAL ON AGING-REVUE CANADIENNE DU VIEILLISSEMENT 14 (3): 511-524 SHAY JW; WERBIN H; WRIGHT WE YOU HAVENT HEARD THE END OF IT - TELOMERE LOSS MAY LINK HUMAN AGING WITH CANCER | 13 | 19 |
982 | 4 | 76 | 5767 2005 CANADIAN PSYCHOLOGY-PSYCHOLOGIE CANADIENNE 46 (3): 115-125 Hawkley LC; Berntson GG; Engeland CG; Marucha PT; Masi CM; et al. Stress, aging, and resilience: Can accrued wear and tear be slowed? | 0 | 0 |
983 | 7 | 26 | 803 1990 CANCER 65 (12): 2697-2703 BRIDGE JA; NEFF JR; BHATIA PS; SANGER WG; MURPHEY MD CYTOGENETIC FINDINGS AND BIOLOGIC BEHAVIOR OF GIANT-CELL TUMORS OF BONE | 6 | 50 |
984 | 9 | 30 | 1418 1994 CANCER 73 (12): 2978-2984 ODAGIRI E; KANDA N; JIBIKI K; DEMURA R; AIKAWA E; et al. REDUCTION OF TELOMERIC LENGTH AND C-ERBB-2 GENE AMPLIFICATION IN HUMAN BREAST-CANCER, FIBROADENOMA, AND GYNECOMASTIA - RELATIONSHIP TO HISTOLOGIC GRADE AND CLINICAL-PARAMETERS | 28 | 44 |
985 | 12 | 26 | 1613 1995 CANCER 75 (5): 1094-1099 SCHWARTZ HS; JULIAO SF; SCIADINI MF; MILLER LK; BUTLER MG TELOMERASE ACTIVITY AND ONCOGENESIS IN GIANT-CELL TUMOR OF BONE | 26 | 45 |
986 | 5 | 28 | 1614 1995 CANCER 75 (7): 2027-2035 SOMMERFELD HJ; MEEKER AK; POSADAS EM; COFFEY DS FRONTIERS IN PROSTATE-CANCER - TELOMERES AND CHAOS | 4 | 12 |
987 | 13 | 28 | 1852 1996 CANCER 77 (8): 1747-1751 Ohashi K; Tsutsumi M; Nakajima Y; Kobitsu K; Nakano H; et al. Telomere changes in human hepatocellular carcinomas and hepatitis virus infected noncancerous livers | 13 | 26 |
988 | 12 | 19 | 1853 1996 CANCER 78 (2): 232-236 Nouso K; Urabe Y; Higashi T; Nakatsukasa H; Hino N; et al. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma | 42 | 70 |
989 | 15 | 29 | 2158 1997 CANCER 79 (2): 362-369 Yoshida K; Sugino T; Tahara H; Woodman A; Bolodeoku J; et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine | 73 | 149 |
990 | 20 | 37 | 2159 1997 CANCER 79 (8): 1552-1560 Iwama H; Ohyashiki K; Ohyashiki JH; Hayashi S; Kawakubo K; et al. The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic myeloid leukemia | 17 | 31 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
991 | 15 | 27 | 2160 1997 CANCER 80 (3): 471-476 Nakatani K; Yoshimi N; Mori H; Yoshimura S; Sakai H; et al. The significant role of telomerase activity in human brain tumors | 24 | 38 |
992 | 24 | 32 | 2161 1997 CANCER 80 (6): 1085-1092 Murakami J; Nagai N; Ohama K; Tahara H; Ide T Telomerase activity in ovarian tumors | 15 | 34 |
993 | 11 | 23 | 2517 1998 CANCER 82 (1): 176-179 Kubota Y; Nakada T; Sasagawa I; Yanai H; Itoh K Elevated levels of telomerase activity in malignant pheochromocytoma | 15 | 42 |
994 | 11 | 22 | 2518 1998 CANCER 82 (4): 708-714 Kavaler E; Landman J; Chang YL; Droller MJ; Liu BCS Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity | 32 | 94 |
995 | 15 | 26 | 2519 1998 CANCER 82 (7): 1319-1327 Yashima K; Ashfaq R; Nowak J; Von Gruenigen V; Milchgrub S; et al. Telomerase activity and expression of its RNA component in cervical lesions | 26 | 41 |
996 | 16 | 31 | 2520 1998 CANCER 82 (10): 1831-1838 Hytiroglou P; Kotoula V; Thung SN; Tsokos M; Fiel MI; et al. Telomerase activity in precancerous hepatic nodules | 15 | 37 |
997 | 19 | 42 | 2521 1998 CANCER 83 (4): 760-766 Yoshida K; Sakamoto S; Sumi S; Higashi Y; Kitahara S Telomerase activity in renal cell carcinoma | 2 | 4 |
998 | 18 | 31 | 2522 1998 CANCER 83 (4): 772-776 Hirano Y; Fujita K; Suzuki K; Ushiyama T; Ohtawara Y; et al. Telomerase activity as an indicator of potentially malignant adrenal tumors | 4 | 17 |
999 | 15 | 27 | 2523 1998 CANCER 83 (12): 2554-2560 Ohyashiki K; Yahata N; Ohyashiki JH; Iwama H; Hayashi S; et al. A combination of semiquantative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia | 8 | 18 |
1000 | 7 | 236 | 2950 1999 CANCER 85 (2): 257-272 Engelberg H Actions of heparin that may affect the malignant process | 1 | 69 |
Page 10 of 66: [ 1 2 3 4 5 6 7 8 9 10 ] 11 21 31 41 51 61
Generated by
HistCite 2006.08.14